Continuously infused methylene blue modulates the early cardiopulmonary response to endotoxin in awake sheep

O V Evgenov1, B Sveinbjørnsson, L J Bjertnaes

  • 1Department of Anesthesiology, Faculty of Medicine, University of Tromsø, Tromsø, Norway.

Abstract

Insights

Methylene blue (MB) infusion counteracts myocardial depression and hypotension in endotoxemia by inhibiting nitric oxide (NO) pathways. This study shows MB improves hemodynamics and gas exchange in endotoxemic sheep.

Area of Science:

  • Cardiovascular Physiology
  • Sepsis Pathophysiology
  • Pharmacology

Background:

  • Endotoxemia and septic shock involve increased nitric oxide (NO) production, leading to myocardial depression, hypotension, and impaired gas exchange.
  • Methylene blue (MB) is an inhibitor of the NO pathway.

Purpose of the Study:

  • To investigate the hypothesis that continuous infusion of MB would counteract the detrimental effects of NO in endotoxemic sheep.

Main Methods:

  • Twenty-one instrumented sheep received either MB or saline intravenously, followed by Escherichia coli endotoxin infusion.
  • MB was administered as an initial bolus and continuous infusion during endotoxemia.
  • Control groups received saline or MB alone.

Main Results:

  • MB prevented endotoxin-induced decreases in stroke volume, cardiac indices, and mean arterial pressure.
  • MB ameliorated pulmonary hypertension and improved oxygenation and delivery.
  • MB prevented hyperthermia, reduced plasma nitrites/nitrates, and delayed lactate elevation.

Conclusions:

  • Continuous MB infusion effectively counteracts early myocardial dysfunction, hemodynamic derangement, and gas exchange abnormalities in ovine endotoxemia.
  • MB demonstrates therapeutic potential in managing sepsis-induced cardiovascular and respiratory compromise.

Related Concept Videos